On Monday, the Justice Department declined a request by House Judiciary Committee Chairman Jerry Nadler, D-N.Y., that it send top officials to testify at an oversight hearing — or at least what was portrayed by the House as an oversight hearing; it was depicted by DOJ as more election-year political theater.
DOJ’s position traces to two developments in July.
First, as I recounted here, the Supreme Court decided Trump v. Mazars, which involved subpoenas issued by House committees for President Trump’s personal financial information.
Anti-Trump derangement of House Democrats has unintended consequences
- by: Andrew McCarthy
- 09.24.20
- Source:
Fox News
- 09/25/2020
Appeals Court by Billy Hathon is licensed under Creative Commons Creative Commons
Appeals Court by Billy Hathon is licensed under Creative Commons Creative Commons
Follow us
Read our latest news on any of these social networks!
Get latest news delivered daily!
We will send you breaking news right to your inbox
Have a tip? Let us know!
Recent Articles
- by: Gabe Cohen
- Source:
CNN
- 06/04/2025
FEMA head told staff he was previously unaware US has a hurricane season
Staff at the Federal Emergency Management Agency were caught off-guard and left bewildered when the disaster relief agency’s new acting head David Richardson told personnel that he was previously unaware the United States has a hurricane season, which started Sunday.
- by: Daniel Chaitin
- Source:
Daily Wire
- 06/04/2025
Trump Puts Rand Paul On Blast Over ‘Big, Beautiful Bill’
President Donald Trump singled out Sen. Rand Paul (R-KY) for criticism on Tuesday in a dispute over the “One Big, Beautiful Bill.”
- by: Alec Schemmel
- Source:
Fox News
- 06/04/2025
White House stands by tax bill after Musk calls it a 'disgusting abomination'
The White House defended the President Donald Trump-endorsed "big, beautiful bill" Tuesday after outgoing DOGE chief Elon Musk doubled down on his criticism, calling the legislation a "disgusting abomination."
- by: Aria Bendix
- Source:
NBC News
- 06/03/2025
FDA grants limited approval to new Covid vaccine from Moderna
The agency approved the company's lower-dose Covid vaccine for older adults and young people with underlying medical conditions.